According to the literature, KRAS mutations occur in 35% to 45% of CRC, mostly in codon 12 (80%), c.35 G > A (G12D), and c.35 G > T (G12V) transversions, representing 32.5% of KRAS mutations [39]. The gene discussed is KRAS; the disease is colorectal carcinoma.